Citation Impact
55 standout
Citing Papers
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
2020 Standout
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
2019 Standout
Works of J.P. Bahary being referenced
Report of NRG Oncology/RTOG 9601, A Phase 3 Trial in Prostate Cancer: Anti-androgen Therapy (AAT) With Bicalutamide During and After Radiation Therapy (RT) in Patients Following Radical Prostatectomy (RP) With pT2-3pN0 Disease and an Elevated PSA
2015
Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)
2014
Author Peers
| Author | PRM | Radiation | Genetics | Neurology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| J.P. Bahary | 199 | 52 | 179 | 100 | 21 | 381 | |
| Underwood Dudley | 25 | 271 | |||||
| Noman Siddiqi | 6 | 4 | 2 | 14 | 1.1k | ||
| Stefan Weis | 1 | 8 | 2.0k | ||||
| Satoshi Chinaka | 2 | 2 | 35 | 606 | |||
| Gebeyaw Getnet | 2 | 12 | 381 |
All Works
Loading papers...